热门资讯> 正文
Roivant Sciences制定5亿美元股票回购计划
2025-06-25 19:51
- Roivant Sciences (NASDAQ:ROIV) has set a stock repurchase program to buy back up to $500M of its common shares.
- The program will be funded with available cash and cash equivalents on hand and does not have an expiration date.
- This new authorization is in addition to the $1.5B common share repurchase program announced in April 2024, which had ~$205M of remaining capacity as of March 31, 2025 and has since been fully exhausted.
More on Roivant Sciences
- Roivant Sciences Ltd. (ROIV) Q4 2024 Earnings Call Transcript
- Roivant Sciences Ltd. 2024 Q4 - Results - Earnings Call Presentation
- Roivant Sciences: Primed For Growth With A De-Risked Pipeline
- Roivant signals pivotal data readouts and potential multi-blockbuster launches over next 36 months
- Immunovant makes leadership changes
推荐文章
一周财经日历丨降息信号将定？下周全球央行年会成关键；小米、泡泡玛特、快手领衔港股财报潮
港股周报丨见证历史！南向资金单日疯狂买入港股359亿港元；腾讯绩后股价一度升破600港元
特朗普政府据悉考虑动用芯片法案资金来入股英特尔
美股机会日报丨“恐怖数据”符合预期，交易员下调美联储降息预期；巴菲特Q2新建仓股飙升，联合健康盘前涨超10%
银诺医药-B上市首日暴涨285%，一手赚超1万港元
投资大佬Tepper减持阿里巴巴、京东等 买入股价暴跌的联合健康
伯克希尔减持苹果股份 增持联合健康集团
8月15日外盘头条：特朗普政府洽购英特尔股份 贝森特否认推动降息 苹果重新设计Apple Watch血氧功能
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
